Why the study?
Does treadmill walking 4 x 30 minutes/week compared to 2 x 60 minutes/week improve heart rate variability and haemorheology in women aged 65-74 years with type 2 diabetes?
Does treadmill walking 4 x 30 minutes/week compared to 2 x 60 minutes/week improve heart rate variability and haemorheology in women aged 65-74 years with type 2 diabetes?
In older women with type 2 diabetes, 12 weeks of treadmill walking improved red blood cell aggregation regardless of session frequency, but more frequent, shorter sessions (4x30 min/week) were required to improve heart rate variability.
May support 4×30 min/week sessions for HRV gains in older diabetic women; extends exercise dosing evidence for hemorheology and autonomic outcomes.
Heart rate variability (HRV) and haemorheology adaptations to 12 wk of varied-dose treadmill walking were investigated in women aged 65-74 yr with type 2 diabetes. Subjects were randomly allocated into two groups where exercise frequency and session duration were manipulated (Group 1: 2 × 60 min·wk(-1) or Group 2: 4 × 30 min·wk(-1)), but intensity and accumulated weekly duration of exercise were consistent between groups (100% gas-exchange threshold; 120 min·wk(-1)). Twelve weeks of exercise training significantly improved peak oxygen uptake, time to exhaustion, and gas-exchange threshold (p < 0.05), independent of exercise group. Exercise training did not significantly change glycaemic control or body mass. Red blood cell (RBC) aggregation and RBC deformability significantly decreased (p < 0.05) for both groups. No change in HRV was observed for Group 1, whereas several key indicators of HRV were significantly improved in Group 2 (p < 0.05). The present study was the first to report decreased RBC aggregation following an exercise-only intervention and that exercise training improved RBC aggregation without a concomitant improvement in glycaemic control. The accumulated weekly exercise duration may be the most important training component for the prescription of exercise in older women with type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Simmonds et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: